Thrombosis Research 1982-11-15

Analysis of the procoagulant activities of factor IX concentrates.

I J Mackie, M J Seghatchian

Index: Thromb. Res. 28(4) , 499-507, (1982)

Full Text: HTML

Abstract

The Factor VIII content of Factor IX concentrates was investigated by agarose gel electrophoresis which removed the interfering effects of stabilisers and proteolytic enzyme inhibitors. Factor VIII coagulant activity (FVIII C) as measured by clotting and amidolytic methods correlated well with the distribution of FVIII coagulant antigen (FVIII CAg). The FVIIIC activity was apparently not entirely due to the presence of activated coagulation enzymes, since none of the enzymicity patterns observed with various chromogenic substrates correlated completely with the FVIII peak. However, some enzyme activity was detected in positions coincident with the margins of the FVIII peak; these activities may represent complexes of some of the FVIII with activated coagulation factors.

Related Compounds

Related Articles:

Heparin and protease inhibition. I. Heparin complexes with thrombin, plasmin, and trypsin.

1981-01-01

[Thromb. Res. 22(1-2) , 103-14, (1981)]

Synthesis of Bz-Phe(p-No2)-Val-Arg-pNA-and its specificity to thrombin-like enzymes: similarity of a commercial product S-2160 to the nitrated compound.

1980-01-01

[Thromb. Res. 20(5-6) , 533-72, (1980)]

Hydrolysis of N-alpha-benzoyl-L-phenylalanyl-L-valyl-L-arginine-p-nitroanilide by human alpha thrombin in the presence of heparin.

1980-01-01

[Thromb. Res. 17(1-2) , 83-90, (1980)]

Radioisotopic measurement of plasma kallikrein.

1982-09-15

[Thromb. Res. 27(6) , 641-9, (1982)]

Inhibition of human coagulation factor Xa by thrombin substrates.

1981-09-15

[Thromb. Res. 23(6) , 533-9, (1981)]

More Articles...